Cargando…
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
OBJECTIVE: Osteosarcoma (OS) is an aggressive, highly metastatic, relatively drug-resistant bone tumor with poor long-term survival rates. The presence and persistence of circulating tumor cells (CTCs) in the peripheral blood are believed to be associated with treatment inefficiency and distant meta...
Autores principales: | Mu, Haoran, Zuo, Dongqing, Chen, Jie, Liu, Zhigang, Wang, Zhuo, Yang, Liu, Shi, Qihui, Hua, Yingqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500224/ https://www.ncbi.nlm.nih.gov/pubmed/36172793 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0279 |
Ejemplares similares
-
Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case–control study
por: Zuo, Dongqing, et al.
Publicado: (2013) -
Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma
por: Sun, Mengxiong, et al.
Publicado: (2022) -
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
por: Jiang, Yafei, et al.
Publicado: (2022) -
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
por: Fu, Zeze, et al.
Publicado: (2013) -
Detection of circulating tumor DNA in patients with osteosarcoma
por: Barris, David M., et al.
Publicado: (2018)